Pamela Vig - 10 Nov 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Head of Research & Development
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 Nov 2023
Net transactions value
+$11,745
Form type
4
Filing time
15 Nov 2023, 20:14:53 UTC
Previous filing
05 Jul 2023
Next filing
09 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $11,745 +527 +1.7% $22.29 31,313 10 Nov 2023 Direct F1
holding MIRM Common Stock 75,000 10 Nov 2023 By The Vig-Ancock Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 527 shares by the Reporting Person on November 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.